Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Blood Thinner Recalled
11/03/2022
A prescription blood thinner is under a Class II recall because the drug is subpotent.
A prescription blood thinner is under a Class II recall because the drug is subpotent.
A prescription blood thinner is...
11/03/2022
Pharmacy Learning Network

Advertisement

News
Vial Breakage Reports Lead to Class I Recall
11/03/2022
Exela Pharma Sciences is voluntarily recalling sodium bicarbonate injections due to reports of vial breakage and flying glass.
Exela Pharma Sciences is voluntarily recalling sodium bicarbonate injections due to reports of vial breakage and flying glass.
Exela Pharma Sciences is...
11/03/2022
Pharmacy Learning Network
News
Tablet Mix-Up Prompts Class I Recall
11/03/2022
A Class I recall has been issued for atenolol tablets due to a bottle mistakenly containing clopidogrel.
A Class I recall has been issued for atenolol tablets due to a bottle mistakenly containing clopidogrel.
A Class I recall has been issued...
11/03/2022
Pharmacy Learning Network
News
Antibiotic Capsules Recalled
10/27/2022
Golden State Medical Supply Inc is recalling a prescription antibiotic used to treat tuberculosis.
Golden State Medical Supply Inc is recalling a prescription antibiotic used to treat tuberculosis.
Golden State Medical Supply Inc...
10/27/2022
Pharmacy Learning Network

Advertisement

News
Nasal Spray Recalled
10/27/2022
A prescription nasal spray used to treat rhinitis is being recalled for failing to meet impurity specifications.
A prescription nasal spray used to treat rhinitis is being recalled for failing to meet impurity specifications.
A prescription nasal spray used...
10/27/2022
Pharmacy Learning Network
News
Leaky IV Bags Recalled
10/27/2022
A Class II recall has been issued for thousands of cases of 0.9% sodium chloride injection due to product leakage.
A Class II recall has been issued for thousands of cases of 0.9% sodium chloride injection due to product leakage.
A Class II recall has been...
10/27/2022
Pharmacy Learning Network
News
Researchers Accelerate Efforts to Develop Epstein-Barr Vaccine
10/25/2022
Efforts to develop an Epstein-Barr vaccine have ramped up amid advances in vaccine technology and research linking the virus to multiple sclerosis and other conditions.
Efforts to develop an Epstein-Barr vaccine have ramped up amid advances in vaccine technology and research linking the virus to multiple sclerosis and other conditions.
Efforts to develop an...
10/25/2022
Pharmacy Learning Network

Advertisement

News
Many Patients Unaware of Pharmacy Medicare Part D Consultation Services
10/20/2022
"Pharmacists may benefit from considering how services are offered to patients based on the specific preferences and expectations and consider ways to increase awareness of service offerings," researchers said.
"Pharmacists may benefit from considering how services are offered to patients based on the specific preferences and expectations and consider ways to increase awareness of service offerings," researchers said.
"Pharmacists may benefit from...
10/20/2022
Pharmacy Learning Network
News
Travel Time, Income May Deter Clinical Pharmacy Use by AI/AN Adults With CVD
10/20/2022
Social determinants of health, such as location and household income, influenced American Indian and Alaska Native individuals' use of clinical pharmacy services.
Social determinants of health, such as location and household income, influenced American Indian and Alaska Native individuals' use of clinical pharmacy services.
Social determinants of health,...
10/20/2022
Pharmacy Learning Network
News
Pharmacist Intervention Saves Hospital More Than $100,000 Over 1 Year
10/20/2022
Tracing reports by pharmacists resulted in cost savings by reducing leftover medications and prompting pharmaceutical interventions for patient safety.
Tracing reports by pharmacists resulted in cost savings by reducing leftover medications and prompting pharmaceutical interventions for patient safety.
Tracing reports by pharmacists...
10/20/2022
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use